Gene · 5893
Papers2,797
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,797
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oligogenic basis of premature ovarian insufficiency: an observational study. | J Ovarian Res | 2024 | 38310280 | PubTator, text mining | PubMed |
| Optimizer's dilemma: optimization strongly influences model selection in transcriptomic prediction. | Bioinform Adv | 2024 | 38282973 | PubTator, text mining | PubMed |
| Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. | Int J Mol Sci | 2024 | 38279263 | PubTator, text mining | PubMed |
| From Churchill to Elephants: The Role of Protective Genes against Cancer. | Genes (Basel) | 2024 | 38255007 | PubTator, text mining | PubMed |
| Alternative Lengthening of Telomeres in Yeast: Old Questions and New Approaches. | Biomolecules | 2024 | 38254712 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype. | Discov Oncol | 2024 | 38228856 | PubTator, text mining | PubMed |
| Distinct modes of telomere synthesis and extension contribute to Alternative Lengthening of Telomeres. | iScience | 2024 | 38213617 | PubTator, text mining | PubMed |
| Replication Protein A, the Main Eukaryotic Single-Stranded DNA Binding Protein, a Focal Point in Cellular DNA Metabolism. | Int J Mol Sci | 2024 | 38203759 | PubTator, text mining | PubMed |
| miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia. | Oncol Lett | 2024 | 38192661 | PubTator, text mining | PubMed |
| A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations. | Diagn Pathol | 2024 | 38184614 | PubTator, text mining | PubMed |
| ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. | Theranostics | 2024 | 38169509 | PubTator, text mining | PubMed |
| The landscape of SETBP1 gene expression and transcription factor activity across human tissues. | PLoS One | 2024 | 38165902 | PubTator, text mining | PubMed |
| Phase separation in DNA double-strand break response. | Nucleus | 2024 | 38146123 | PubTator, text mining | PubMed |
| Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells. | Nucleic Acids Res | 2024 | 38109306 | PubTator, text mining | PubMed |
| Human RAD52 stimulates the RAD51-mediated homology search. | Life Sci Alliance | 2024 | 38081641 | PubTator, text mining | PubMed |
| MutSβ protects common fragile sites by facilitating homology-directed repair at DNA double-strand breaks with secondary structures. | Nucleic Acids Res | 2024 | 38038265 | PubTator, text mining | PubMed |
| Analysis of the indispensable RAD51 cofactor BRCA2 in Naganishia liquefaciens, a Basidiomycota yeast. | Life Sci Alliance | 2024 | 38016757 | PubTator, text mining | PubMed |
| Massive contractions of myotonic dystrophy type 2-associated CCTG tetranucleotide repeats occur via double-strand break repair with distinct requirements for DNA helicases. | G3 (Bethesda) | 2024 | 37950892 | PubTator, text mining | PubMed |
| PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation. | J Clin Invest | 2024 | 37934606 | PubTator, text mining | PubMed |
| Identification of small molecule inhibitors of RAD52 for breast cancer therapy: in silico approach. | J Biomol Struct Dyn | 2024 | 37288783 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5893/papers?page=6